contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


zealand-pharma-to-participate-in-upcoming-healthcare-investor-conferences-in-may-and-june-2025

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Zealand Pharma is a biotechnology company. Particular focus is found in the development of drugs for the treatment of diabetes and various intestinal diseases. The company has a varied product portfolio with separate brands that are sold on a global level. The largest business is in the Nordic market. Zealand Pharma was founded in 1997 and is headquartered in Söborg, Denmark.

Zealand Pharma

Press release – No. 8 / 2025 Zealand Pharma to participate in upcoming healthcare investor conferences in May and June 2025 Copenhagen, Denmark, May 12, 2025 – Zealand Pharma A/S (Nasdaq: ZEAL...

Press release – No. 8 / 2025 Zealand Pharma to participate in upcoming healthcare investor conferences in May and June 2025 Copenhagen, Denmark, May 12, 2025 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that the company will participate in the following healthcare investor conferences in May and June 2025: <ul><li>Bank of America Global Healthcare Conference, May 13-15 in Las Vegas</li></ul> David Kendall, Executive Vice President and Chief Medical Officer, will present on Wednesday, May 14 at 8:00am PT (5:00pm CET). A live audio webcast of the presentation will be available at <a href="https://www.globenewswire.com/Tracker?data=Ybzt5GzG_eoSo41NLigqa_oWmAsfjy614VQShNBm7kcJNQSCXYBGU6Wx_0qX8eDFivcCPROomfi29BL1d6GCsQPEvixW6I_a5VN1-J3ISRCe5qPrPByX1wbnbMLMYnyWI23mFwPiay-Ce8AF3lmAEXSEy8FD7pw3PzTq1JavEGzKvLI7ZbgXmM6nvZLKy9cEAYDpOsyOzarlmBlzrwxts1PWTdb2eC85ErYtmA9C4BQ=">https://bofa.veracast.com/webcasts/bofa/healthcare2025/id0V27z5.cfm</a>. <ul><li>Berenberg European Conference, May 20-22 in New York</li></ul> Adam Steensberg, President and Chief Executive Officer, to host investor meetings on Tuesday, May 20. <ul><li>Barclays European Leadership Conference, May 22 in London</li></ul> David Kendall, Executive Vice President and Chief Medical Officer to participate in a panel discussion about obesity on Thursday, May 22 at 11:30am UKT (12:30pm CET). The panel will not be webcast. &nbsp; <ul><li>Jefferies Global Healthcare Conference, June 3-5 in New York</li></ul> Anna Krassowska, Vice President, Investor Relations &amp; Corporate Communications to participate in a fireside chat on Thursday, June 5 at 11:40am ET (5:40pm CET). The fireside chat will not be webcast. <ul><li>Goldman Sachs Annual Global Healthcare Conference, June 9-11 in Miami</li></ul> Adam Steensberg, President and Chief Executive Officer, to participate in fireside chat on Wednesday, June 11 at 4:00pm ET (10:00pm CET). A webcast of the fireside chat will be available at <a href="https://www.globenewswire.com/Tracker?data=Ybzt5GzG_eoSo41NLigqa2lId7m70O9pdmtBionbSsMh63_mSYZeks7g0VebdAC34uHfmOllV5fbHjWRFM2hxzT8zdHM5tuxlSbdsTjTwCq3fapRuk55wVJoSCcIIJr58jnycUs9qVIGJkspO5L9yw==">https://www.zealandpharma.com/events/</a> in the coming weeks, where replays of all webcasts are also archived. About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products. Zealand Pharma was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in the U.S. For more information about Zealand Pharma’s business and activities, please visit <a href="https://www.globenewswire.com/Tracker?data=teN6K2ZFmn3b2K8jwrw1Gia3DxoUaP-rx6XZMlj-t8LP4oB5yG970g8N-n0wyc7xEvJfTgbE5R8dOQlDoVnokQ_TE-6FcmZmhe6xt2oKh1Q=">www.zealandpharma.com</a>. Contacts Adam Lange (Investors) Vice President, Investor Relations alange@zealandpharma.com Neshat Ahmadi (Investors) Investor Relations Manager neahmadi@zealandpharma.com Anna Krassowska, PhD (Investor and Media) Vice President, Investor Relations &amp; Corporate Communications akrassowska@zealandpharma.com <img src="https://www.globenewswire.com/newsroom/ti?nf=MTAwMTA5NTg2NyM0MDIxMzk0MzkjMjAwMTcwMQ==" alt=""> <img src="https://ml-eu.globenewswire.com/media/NWRhMDQyNzEtYzUxMi00Njk0LTgyNzctNTJiMWQ0MGY3YzlkLTEwMTMyNzQtMjAyNS0wNS0xMi1lbg==/tiny/Zealand-Pharma.png" alt="">

Zealand Pharma to participate in upcoming healthcare investor conferences in May and June 2025